Brevan Howard Capital Management’s Enovis ENOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$308K Sell
14,891
-686
-4% -$16.2K ﹤0.01% 1698
2026
Q1
$354K Buy
+15,577
New +$368K ﹤0.01% 1514
2025
Q4
– Sell
-46,636
Closed -$1.41M – 1929
2025
Q3
$1.41M Buy
46,636
+2,540
+6% +$77K 0.01% 737
2025
Q2
$1.38M Buy
+44,096
New +$1.46M 0.01% 913
2024
Q4
– Sell
-9,402
Closed -$405K – 1148
2024
Q3
$405K Buy
+9,402
New +$419K ﹤0.01% 748
2024
Q1
– Sell
-13,760
Closed -$771K – 1092
2023
Q4
$771K Buy
+13,760
New +$686K 0.01% 320

Other funds holding ENOV

Brevan Howard Capital Management's ENOV Position: Q2 2026 in Review

Brevan Howard Capital Management reduced its Enovis (ENOV) stake by 4.4% in Q2 2026, selling an estimated $16.2K and leaving 14,891 shares worth $308K. The position accounts for ﹤0.01% of the portfolio, ranked #1698.

Brevan Howard Capital Management first reported a position in ENOV in Q4 2023 and has held it in 6 quarters since. The position peaked at $1.41M in Q3 2025. 253 funds tracked by Wall St. Rank hold ENOV as of Q2 2026.

  • Brevan Howard Capital Management held 14,891 shares of Enovis worth $308K as of Q2 2026.
  • Brevan Howard Capital Management sold 686 Enovis shares in Q2 2026, an estimated $16.2K.
  • Enovis made up ﹤0.01% of Brevan Howard Capital Management's portfolio in Q2 2026, its #1698 holding.
  • Brevan Howard Capital Management first reported a position in Enovis in Q4 2023 and has held it in 6 quarters since.
  • Brevan Howard Capital Management's Enovis position peaked at $1.41M in Q3 2025.
  • 253 funds tracked by Wall St. Rank held Enovis as of Q2 2026.

Based on Brevan Howard Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.